Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 468
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05922345 | Evaluation of the Efficacy and Safety of AL2846 Capsule Combined With TQB2450 Injection Compared to Docetaxel Injection in Advanced Non-small Cell Lung Cancer Patients Who Have Failed With Immunotherapy. | ||
| NCT05476341 | A Phase I Clinical Trial of Bevacizumab Injection | ||
| NCT06851442 | Clinical Trial of Evaluating TQB3912 Tablets Combined With Fulvestrant Injection±TQB3616 Capsules for Locally Advanced or Metastatic Hormone Receptor(HR)-Positive and Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer | ||
| NCT03456466 | Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's Lymphoma | ||
| NCT04619563 | A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients | ||
| NCT03457844 | A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3 | ||
| NCT04398940 | A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer | ||
| NCT06010901 | A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. | ||
| NCT03790228 | Anlotinib Combined With Pemetrexed And Carboplatin as First-line Treatment in Advanced Nonsquamous NSCLC | ||
| NCT07165951 | Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules With Placebo Combined With Chemotherapy as First-line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) | ||
| NCT04080843 | Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | ||
| NCT02332499 | Study of Anlotinib in Patients With Metastatic Colorectal Cancer(mCRC)(ALTER0703) | ||
| NCT05306847 | Sintilimab Combined With Anlotinib Therapy for Initially Unresectable Non-small Cell Lung Cancer | ||
| NCT05145218 | A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer | ||
| NCT06754891 | Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease | ||
| NCT06431490 | A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer | ||
| NCT06725641 | Bioequivalence Study of Methacholine for Inhalation (pharmacodynamics) | ||
| NCT05496569 | TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma | ||
| NCT06198751 | A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer | ||
| NCT05198505 | Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors | ||
| NCT05262335 | Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001) | ||
| NCT06990776 | A Clinical Trial to Evaluate the Efficacy and Safety of TQA3605 Tablets in Treatment-naive Chronic HBV-infected Subjects | ||
| NCT04326348 | A Study of TQ05105 Tablets in Subjects With Hemophagocytic Lymphohistiocytosis(HLH) | ||
| NCT06700395 | A Clinical Study of TQB2029 for Injection in Subjects With Multiple Myeloma | ||
| NCT03910127 | Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer(NSCLC) | ||
| NCT07608666 | Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets | ||
| NCT03850873 | A Phase I Study of TQB3616 on Tolerance and Pharmacokinetics | ||
| NCT03743129 | Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer(ALTER-L029) | ||
| NCT04975204 | A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors | ||
| NCT06672276 | To Evaluate the Pharmacokinetics and Safety of TQD3606 for Injection in Subjects With Renal Insufficiency | ||
| NCT04675060 | Effect of High-fat Meal on the Pharmacokinetics of TQ-B3139 Capsules | ||
| NCT01926288 | Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B | ||
| NCT02287857 | Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B | ||
| NCT06278493 | A Clinical Study of AL2846 Capsule Combined With Gemzar Injection in the Treatment of Advanced Pancreatic Cancer | ||
| NCT04804904 | A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects | ||
| NCT03589950 | Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer | ||
| NCT07008976 | Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer | ||
| NCT06500091 | TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors | ||
| NCT04128085 | A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors | ||
| NCT05489276 | Clinical Trial of TQB2825 in Subjects With CD20 Positive Hematological Tumors | ||
| NCT06297655 | A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A | ||
| NCT02779699 | A Study of AL2846 on Tolerance and Pharmacokinetics | ||
| NCT06452693 | A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B | ||
| NCT06569524 | Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH) | ||
| NCT04955834 | A Clinical Study of Insulin Degludec Injection in Subjects With Type 2 Diabetes | ||
| NCT03996408 | Study of TQB2450 Combined With Anlotinib in Subjects With Advanced Cholangiocarcinoma | ||
| NCT04324879 | A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) | ||
| NCT04398953 | A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL) | ||
| NCT07798284 | A Clinical Trial of TQF3250 Capsules in Overweight/Obese Trial Participants With Poor Weight Control Through Simple Lifestyle Intervention | ||
| NCT03777085 | Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL) |
